Brainsway (BWAY) Total Non-Current Liabilities (2018 - 2025)

Brainsway (BWAY) posted quarterly Total Non-Current Liabilities of $17.5 million for Q4 2025, up 5.26% year-on-year from $16.7 million in Q4 2024, and up 463.08% on a QoQ basis from -$4.8 million in Q3 2025.

Brainsway (BWAY) Total Non-Current Liabilities (2018 - 2025) Analysis & Trends

Brainsway (BWAY) has reported Total Non-Current Liabilities for 8 consecutive years, with $17.5 million the latest figure, recorded in Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 5.26% year-over-year to $17.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $17.5 million (up 5.26% YoY) and the FY2025 annual result came in at $17.5 million, up 5.26% from the prior year.
  • Total Non-Current Liabilities improved to $17.5 million in Q4 2025 per BWAY's latest filing, from -$4.8 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for BWAY reached as high as $17.9 million in Q2 2025 and fell as low as -$4.8 million in Q3 2025.
  • A 5-year average of $9.6 million and a median of $11.3 million in 2022 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2024 — Total Non-Current Liabilities soared 43.22% — and 2025, when it gained 5.26%.
  • Year by year, Total Non-Current Liabilities stood at $9.3 million in 2021, then climbed by 17.12% to $10.9 million in 2022, then climbed by 6.32% to $11.6 million in 2023, then soared by 43.22% to $16.7 million in 2024, then rose by 5.26% to $17.5 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $17.5 million, -$4.8 million, and $17.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Brainsway 646.63 Mn 587.74 Mn 11.68 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 17.53 Mn
Sep 30, 2025 -4.83 Mn
Jun 30, 2025 17.92 Mn
Mar 31, 2025 -2.13 Mn
Dec 31, 2024 16.66 Mn
Dec 31, 2023 11.63 Mn
Dec 31, 2022 10.94 Mn
Dec 31, 2021 9.34 Mn
Dec 31, 2020 7.58 Mn
Sep 30, 2020 7.50 Mn
Dec 31, 2019 7.80 Mn
Sep 30, 2019 7.80 Mn
Dec 31, 2018 8.31 Mn